TANNER CAVANAUGH: Open Payments
NPI 1811394976 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 19 payments from 10 companies in 2025. Trend: 2023 $1,626 · 2024 $1,752 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $163 |
| Janssen Biotech, Inc. | 2 | $60 |
| Incyte Corporation | 2 | $46 |
| UCB, Inc. | 2 | $45 |
| Kerecis Limited | 4 | $36 |
| ABBVIE INC. | 2 | $36 |
| Amgen Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Organon LLC | 1 | $6 |
Products named: TREMFYA, OPZELURA, Bimzelx, Kerecis SurgiClose, NEMLUVIO, SKYRIZI, Otezla, DUPIXENT.
Industry payments across CA — which companies pay providers there.
